• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自一种栖息于粪便的物种的抗病毒巴弗洛霉素

Antiviral Bafilomycins from a Feces-Inhabiting sp.

作者信息

Xie Xi, Lu Shengsheng, Pan Xiaoyan, Zou Min, Li Fangfang, Lin Haixing, Hu Jianan, Fan Sheng, He Jian

机构信息

Group of Peptides and Natural Products Research, School of Pharmaceutical Sciences, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou 510515, People's Republic of China.

State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, People's Republic of China.

出版信息

J Nat Prod. 2021 Feb 26;84(2):537-543. doi: 10.1021/acs.jnatprod.0c01243. Epub 2021 Feb 8.

DOI:10.1021/acs.jnatprod.0c01243
PMID:33631936
Abstract

A new bafilomycin derivative () and another seven known bafilomycins (-) were isolated from feces-derived sp. HTL16. The structure of was elucidated by 1D and 2D NMR spectroscopic analysis. Biological testing demonstrated that these bafilomycins exhibited potent antiviral activities against the influenza A and SARS-CoV-2 viruses, with IC values in the nanomolar range, by inhibiting the activity of endosomal ATP-driven proton pumps.

摘要

从粪便来源的链霉菌属菌株HTL16中分离出一种新的巴弗洛霉素衍生物()和另外七种已知的巴弗洛霉素(-)。通过一维和二维核磁共振光谱分析阐明了的结构。生物学测试表明,这些巴弗洛霉素通过抑制内体ATP驱动的质子泵的活性,对甲型流感病毒和SARS-CoV-2病毒表现出强大的抗病毒活性,IC值在纳摩尔范围内。

相似文献

1
Antiviral Bafilomycins from a Feces-Inhabiting sp.来自一种栖息于粪便的物种的抗病毒巴弗洛霉素
J Nat Prod. 2021 Feb 26;84(2):537-543. doi: 10.1021/acs.jnatprod.0c01243. Epub 2021 Feb 8.
2
New anti-influenza A viral norsesquiterpenoids isolated from feces-residing Streptomyces sp.从粪便中分离出的新型抗甲型流感病毒倍半萜类化合物——来自链霉菌属菌株
Fitoterapia. 2022 Mar;157:105107. doi: 10.1016/j.fitote.2021.105107. Epub 2021 Dec 22.
3
Antiviral properties of extracts of Streptomyces sp. SMU 03 isolated from the feces of Elephas maximus.从亚洲象粪便中分离出的链霉菌 sp. SMU 03 提取物的抗病毒特性。
Fitoterapia. 2020 Jun;143:104600. doi: 10.1016/j.fitote.2020.104600. Epub 2020 Apr 21.
4
Dihydromaniwamycin E, a Heat-Shock Metabolite from Thermotolerant sp. JA74, Exhibiting Antiviral Activity against Influenza and SARS-CoV-2 Viruses.二氢马尼霉素 E,一种来自耐热 sp. JA74 的热休克代谢产物,具有抗流感和 SARS-CoV-2 病毒的活性。
J Nat Prod. 2022 Nov 25;85(11):2583-2591. doi: 10.1021/acs.jnatprod.2c00550. Epub 2022 Oct 12.
5
Anti-Influenza A Viral Butenolide from sp. Smu03 Inhabiting the Intestine of .肠共生 sp. Smu03 中的抗流感 A 病毒丁烯内酯
Viruses. 2018 Jul 5;10(7):356. doi: 10.3390/v10070356.
6
Sesquiterpenoids isolated from feces-residing sp. inhibit the cellular entry of influenza a viruses.从粪便中分离出的倍半萜类化合物抑制甲型流感病毒的细胞内吞。
Nat Prod Res. 2022 Dec;36(24):6286-6296. doi: 10.1080/14786419.2022.2033740. Epub 2022 Feb 2.
7
Bafilomycins and Odoriferous Sesquiterpenoids from Streptomyces albolongus Isolated from Elephas maximus Feces.从大象粪便中分离得到的白色链霉菌产生的巴佛洛霉素和有臭味的倍半萜。
J Nat Prod. 2016 Apr 22;79(4):799-805. doi: 10.1021/acs.jnatprod.5b00827. Epub 2016 Mar 2.
8
An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.一种M2-V27A通道阻滞剂对金刚烷胺敏感和耐药的甲型流感病毒均表现出强大的体外和体内抗病毒活性。
Antiviral Res. 2017 Apr;140:45-54. doi: 10.1016/j.antiviral.2017.01.006. Epub 2017 Jan 10.
9
Concanamycin A blocks influenza virus entry into cells under acidic conditions.concanamycin A在酸性条件下可阻断流感病毒进入细胞。
FEBS Lett. 1994 Aug 8;349(3):327-30. doi: 10.1016/0014-5793(94)00695-4.
10
Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure-activity relationship analysis.茶多酚对甲型和乙型流感病毒的体外抗病毒活性比较及构效关系分析
Fitoterapia. 2014 Mar;93:47-53. doi: 10.1016/j.fitote.2013.12.011. Epub 2013 Dec 24.

引用本文的文献

1
Biotechnological potential of actinomycetes in the 21st century: a brief review.二十一世纪放线菌的生物技术潜力:简要综述。
Antonie Van Leeuwenhoek. 2024 May 24;117(1):82. doi: 10.1007/s10482-024-01964-y.
2
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China.从实验室到病床:中国小分子抗 SARS-CoV-2 药物的创新。
Eur J Med Chem. 2023 Sep 5;257:115503. doi: 10.1016/j.ejmech.2023.115503. Epub 2023 May 18.
3
Complete Genome Sequence of Streptomyces sp. HP-A2021, a Promising Bacterium for Natural Product Discovery.
链霉菌 sp. HP-A2021 的全基因组序列,一种有前途的天然产物发现的细菌。
Biochem Genet. 2023 Oct;61(5):2042-2055. doi: 10.1007/s10528-023-10350-8. Epub 2023 Mar 16.
4
Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models.利用肺类器官模型开发一个筛选平台,以发现对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染有活性的天然产物。
Biomater Res. 2023 Mar 1;27(1):18. doi: 10.1186/s40824-023-00357-y.
5
Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model.巴弗洛霉素 A1 抑制人肺异种移植小鼠模型中的 SARS-CoV-2 感染。
Virol J. 2023 Jan 31;20(1):18. doi: 10.1186/s12985-023-01971-x.
6
Marine Natural Products as Leads against SARS-CoV-2 Infection.海洋天然产物作为抗 SARS-CoV-2 感染的先导物。
J Nat Prod. 2022 Mar 25;85(3):657-665. doi: 10.1021/acs.jnatprod.2c00015. Epub 2022 Mar 15.
7
Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer.天然产物单独或与美国食品药品监督管理局(FDA)批准的药物联合使用,用于治疗新冠肺炎和肺癌。
Biomedicines. 2021 Jun 18;9(6):689. doi: 10.3390/biomedicines9060689.